CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
March 2020—Standardizing indirect immunofluorescence testing for antinuclear antibodies is a critical task for the laboratory community, and it’s more urgent now that new classification criteria make positive ANA a key factor in diagnosing lupus, said Mark H. Wener, MD, in a session at last year’s American Association for Clinical Chemistry annual meeting.
Read More »Addressing the shortcomings of ANA testing by IFA
